Prostate Cancer - Results from #1440

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study). January 25, 2024

Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study. January 25, 2024

Physician Perception of Grade Group 1 Prostate Cancer. January 25, 2024

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients. January 24, 2024

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas. January 24, 2024

Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical Prostatectomy. January 24, 2024

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. January 24, 2024

Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer. January 24, 2024

Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. January 24, 2024

Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood. January 24, 2024

Functional Outcomes After Localized Prostate Cancer Treatment January 23, 2024

Long-Term Follow up Pinpoints Side Effects of Treatments for Prostate Cancer Patients January 23, 2024

The effect of limited english proficiency on prostate-specific antigen screening in American men. January 23, 2024

Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET. January 23, 2024

The future of patient-derived xenografts in prostate cancer research. January 23, 2024

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts. January 23, 2024

Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review. January 23, 2024

Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients. January 23, 2024

Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis. January 23, 2024

The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. January 22, 2024

Page 73 of 1435